Amplitude Names Andrew Casey CFO; Shares Fall-February 2024-www.financetom.com

Amplitude Names Andrew Casey CFO; Shares Fall

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Amplitude Names Andrew Casey CFO; Shares Fall

Aug 5, 2024 6:55 AM

09:36 AM EDT, 08/05/2024 (MT Newswires) -- Amplitude (AMPL) said Monday that it has named Andrew Casey as its chief financial officer.

Casey was previously finance chief at Lacework.

Shares of Amplitude fell 2.5% in early trading.

Price: 8.55, Change: -0.22, Percent Change: -2.51

Previous page： Kazia Says Paxalisib Disrupts Tumor Cell Clusters in HER2-Positive Breast Cancer Study Next page： OR Royalties Reports Project Advances at Cascabel, Cariboo and Marimaca, Expects Further 2025 Portfolio Growth

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Kazia Says Paxalisib Disrupts Tumor Cell Clusters in HER2-Positive Breast Cancer Study

Sep 11, 2025

08:42 AM EDT, 09/11/2025 (MT Newswires) -- Kazia Therapeutics ( KZIA ) said Thursday that paxalisib monotherapy completely disrupted large circulating tumor cell clusters in blood samples from stage IV HER2-positive breast cancer patients in an ex vivo study conducted by QIMR Berghofer. The company said the treatment also showed statistically significant reduction in single circulating tumor cells, which are...

OR Royalties Reports Project Advances at Cascabel, Cariboo and Marimaca, Expects Further 2025 Portfolio Growth

Sep 11, 2025

08:39 AM EDT, 09/11/2025 (MT Newswires) -- OR Royalties ( OR ) reported Thursday positive updates on some of its assets. SolGold continues to advance the Cascabel project in Ecuador, with first production scheduled as early as 2028. A project execution plan has been delivered while work continues on an environmental impact assessment, OR said. OR's interest in Cascabel include...

Amneal Pharmaceuticals Wins US FDA Approval for Generic Version of Narcolepsy Drug Xyrem

Sep 11, 2025

08:42 AM EDT, 09/11/2025 (MT Newswires) -- Amneal Pharmaceuticals ( AMRX ) said Thursday that the US Food and Drug Administration has approved its generic version of sodium oxybate oral solution, referencing Jazz Pharmaceuticals' ( JAZZ ) Xyrem. The drug is used to treat cataplexy and excessive daytime sleepiness in patients aged 7 and older with narcolepsy, the company said....

Foraco to Repurchase Up to 1 Million Shares Under New Normal Course Issuer Bid

Sep 11, 2025

08:41 AM EDT, 09/11/2025 (MT Newswires) -- Foraco International ( FRACF ) Thursday said the Toronto Stock Exchange has accepted its notice to repurchase up to 1 million shares under a normal course issuer bid. The bid will start Sept. 15 and run for one year. Foraco ( FRACF ) repurchased 956,100 shares under its previous NCIB at a weighted...